Published on 29/12/2025
Investigating Moisture Sensitivity of Enteric-Coated Tablets During Storage
Introduction:
Enteric-coated tablets are a crucial dosage form in the pharmaceutical industry, offering a protective barrier that prevents tablet disintegration in the acidic environment of the stomach. This coating ensures that the active pharmaceutical ingredient (API) is released only in the more neutral pH of the intestines, enhancing drug efficacy and minimizing gastric irritation. However, the enteric coating’s effectiveness can be compromised by moisture during storage, leading to premature disintegration, reduced efficacy, and altered drug release profiles. Understanding and managing moisture sensitivity is essential for maintaining the stability and therapeutic effectiveness of these tablets.
Challenges and Issues:
- Moisture penetration leading to the breakdown of the enteric coating.
- Alteration in dissolution profiles and drug release rates.
- Potential degradation of the active pharmaceutical ingredient (API).
- Inadequate packaging solutions that fail to prevent moisture ingress.
- Variability in storage conditions affecting tablet integrity and shelf life.
Step-by-Step Troubleshooting Guide:
- Identify Moisture Sources: Evaluate the entire manufacturing and packaging process to identify potential moisture sources. This includes assessing raw materials, equipment cleaning processes, and environmental controls in manufacturing areas.
- Improve Coating Formulation: Enhance the enteric coating formulation by incorporating moisture-resistant polymers. Consider experimenting with different polymer combinations and plasticizers
Regulatory Guidelines:
The USFDA provides comprehensive guidelines on the stability testing and storage of pharmaceutical products. According to these guidelines, it is essential to perform stability testing under various temperature and humidity conditions to ensure the integrity of the dosage form throughout its shelf life. The USFDA also emphasizes the importance of robust packaging solutions to protect against moisture ingress. Similarly, the International Council for Harmonisation (ICH) guidelines provide a framework for stability testing, emphasizing the need for rigorous environmental controls and testing protocols.
Conclusion:
Ensuring the stability of enteric-coated tablets during storage is pivotal in maintaining their therapeutic efficacy and safety. By understanding the challenges posed by moisture sensitivity, pharmaceutical professionals can implement effective strategies to mitigate these risks. Improving coating formulations, optimizing packaging solutions, and adhering to stringent regulatory guidelines are key practices to ensure product integrity. Continuous monitoring and stability testing further aid in safeguarding the quality of enteric-coated tablets, ultimately ensuring that patients receive safe and effective medication.